• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童-普奇分类法和梅奥自然史模型在原发性硬化性胆管炎患者生存评估中的相对作用。

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

作者信息

Kim W R, Poterucha J J, Wiesner R H, LaRusso N F, Lindor K D, Petz J, Therneau T M, Malinchoc M, Dickson E R

机构信息

Division of Gastroenterology and Hepatology, Section of Biostatistics, Mayo Clinic and Foundation, Rochester, MN, USA.

出版信息

Hepatology. 1999 Jun;29(6):1643-8. doi: 10.1002/hep.510290607.

DOI:10.1002/hep.510290607
PMID:10347102
Abstract

The Child-Pugh classification is a simple, convenient prognostic measure in patients with liver cirrhosis. We investigated the relative role of the Child-Pugh classification and the Mayo model in the assessment of survival in patients with primary sclerosing cholangitis (PSC). Of the 173 patients described in the original Mayo PSC natural history model, 147 patients had sufficient information in the medical record to allow computation of the Child-Pugh score. We used our most recent modification of the Mayo model to compute the risk score, based on patient's age, serum levels of bilirubin, albumin, and aspartate aminotransferase and history of variceal bleeding. Using the risk score (R), patients were divided into the low- (R < 0), intermediate- (0 </= R < 2), and high-risk (R >/= 2) groups. Kaplan-Meier estimates and proportional hazards analysis were used to evaluate the two prognostic models. Although there was a statistically significant correlation between the Child-Pugh and Mayo risk scores, two-thirds of the patients had a Child-Pugh score of 5 or 6 and a relatively wide range of risk scores (-1.1-4.3). The probability of survival for 7 years in patients in the low-, intermediate-, and high-risk groups was 92%, 74%, and 40% for Child-Pugh class A (n = 96) and 100%, 62%, and 28% for Child-Pugh class B patients (n = 44), respectively. There were only a small number (n = 7) of Child-Pugh class C patients. In our age-adjusted multivariate analysis, each unit increase in the Mayo risk score was associated with a 2.5-fold increase in the risk of death (95% confidence interval: 1.8-3.4, P <.01), whereas Child-Pugh classification had no significant impact on survival (Child-Pugh B vs. A: risk ratio = 1.1 [95% confidence interval: 0.6-2.0]; Child-Pugh C versus A: risk ratio = 0.6 [95% confidence interval: 0. 2-1.8]). In contrast to the Child-Pugh classification, which was developed for advanced liver cirrhosis, the Mayo model provides valid survival information, particularly in patients early in the course of PSC.

摘要

Child-Pugh分级是评估肝硬化患者预后的一种简单、便捷的方法。我们研究了Child-Pugh分级和Mayo模型在原发性硬化性胆管炎(PSC)患者生存评估中的相对作用。在最初的Mayo PSC自然史模型中描述的173例患者中,147例患者的病历中有足够信息以计算Child-Pugh评分。我们使用Mayo模型的最新修订版,根据患者年龄、血清胆红素、白蛋白、天冬氨酸转氨酶水平以及静脉曲张出血史来计算风险评分。利用风险评分(R),将患者分为低风险组(R<0)、中风险组(0≤R<2)和高风险组(R≥2)。采用Kaplan-Meier估计法和比例风险分析来评估这两种预后模型。虽然Child-Pugh评分与Mayo风险评分之间存在统计学显著相关性,但三分之二的患者Child-Pugh评分为5或6,且风险评分范围相对较宽(-1.1至4.3)。Child-Pugh A级(n=96)患者低、中、高风险组的7年生存率分别为92%、74%和40%,Child-Pugh B级患者(n=44)分别为100%、62%和28%。Child-Pugh C级患者数量较少(n=�)。在我们的年龄校正多变量分析中,Mayo风险评分每增加一个单位,死亡风险增加2.5倍(95%置信区间:1.8至3.4,P<.01),而Child-Pugh分级对生存无显著影响(Child-Pugh B级与A级:风险比=1.1[95%置信区间:0.6至2.0];Child-Pugh C级与A级:风险比=0.6[95%置信区间:0.2至1.8])。与针对晚期肝硬化开发的Child-Pugh分级不同,Mayo模型提供了有效的生存信息,尤其是对于PSC病程早期的患者。

相似文献

1
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.儿童-普奇分类法和梅奥自然史模型在原发性硬化性胆管炎患者生存评估中的相对作用。
Hepatology. 1999 Jun;29(6):1643-8. doi: 10.1002/hep.510290607.
2
Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.基于梅奥诊所预后模型的欧洲原发性胆汁性肝硬化人群中Pugh-Child-PBC分类患者的生存概率。欧洲原发性胆汁性肝硬化项目管理组。
Hepatogastroenterology. 1997 Jul-Aug;44(16):982-9.
3
Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.使用梅奥原发性硬化性胆管炎模型和Child-Pugh评分预测肝移植后的临床和经济结局。美国国立糖尿病、消化和肾脏疾病研究所肝移植数据库组。
Liver Transpl. 2000 Nov;6(6):753-8. doi: 10.1053/jlts.2000.18485.
4
Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.与原发性胆汁性肝硬化死亡患者实际生存相关的主要临床事件、体征及严重程度评估分数。一项长期历史性队列研究。
Hepatogastroenterology. 1999 Jan-Feb;46(25):108-15.
5
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis.Child-Pugh分级作为原发性硬化性胆管炎生存预后指标。
Hepatology. 1997 May;25(5):1049-53. doi: 10.1002/hep.510250501.
6
A revised natural history model for primary sclerosing cholangitis.原发性硬化性胆管炎的修订自然史模型。
Mayo Clin Proc. 2000 Jul;75(7):688-94. doi: 10.4065/75.7.688.
7
Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.原发性硬化性胆管炎中的胆道恶性肿瘤:肝移植时机
Hepatology. 1996 May;23(5):1105-11. doi: 10.1002/hep.510230526.
8
Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.预测晚期肝病患者食管或胃静脉曲张存在的因素。
Am J Gastroenterol. 1999 Nov;94(11):3292-6. doi: 10.1111/j.1572-0241.1999.01540.x.
9
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.台湾原发性胆汁性肝硬化的自然病史及预后因素:一项长达18年的随访研究
Liver Int. 2008 Nov;28(9):1305-13. doi: 10.1111/j.1478-3231.2008.01715.x. Epub 2008 Mar 13.
10
Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.梅奥原发性胆汁性肝硬化自然史模型在肝移植候选者中的适应性应用。
Liver Transpl. 2000 Jul;6(4):489-94. doi: 10.1053/jlts.2000.6503.

引用本文的文献

1
Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing Cholangitis.梅奥风险评分在美国单中心原发性硬化性胆管炎队列中预测移植和死亡率的表现
J Clin Med. 2025 Mar 19;14(6):2098. doi: 10.3390/jcm14062098.
2
Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer.小颗粒药物洗脱微球经动脉化疗栓塞联合靶向治疗在不可切除肝癌临床治疗中的应用
World J Gastrointest Oncol. 2024 Oct 15;16(10):4157-4165. doi: 10.4251/wjgo.v16.i10.4157.
3
A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis.
使用定量磁共振胰胆管造影的综合评分可预测原发性硬化性胆管炎的临床结局。
JHEP Rep. 2023 Jun 29;5(10):100834. doi: 10.1016/j.jhepr.2023.100834. eCollection 2023 Oct.
4
Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data.轻度延长凝血酶原时间并不影响经颈静脉肝内门体分流术的安全性和预后:基于真实世界数据。
Turk J Gastroenterol. 2023 Aug;34(8):873-880. doi: 10.5152/tjg.2023.22410.
5
Evaluation of Outcomes and Complications of Large Volume Paracentesis without Albumin and Coagulopathy Therapy in Pediatrics with Severe Ascites.未进行白蛋白及凝血障碍治疗的大量腹腔穿刺术在小儿重度腹水治疗中的结局及并发症评估
Med J Islam Repub Iran. 2023 May 1;37:45. doi: 10.47176/mjiri.37.45. eCollection 2023.
6
Benefit of endoscopic stenting for dominant strictures in patients with primary sclerosing cholangitis.内镜支架置入术对原发性硬化性胆管炎患者主要狭窄的益处。
Endosc Int Open. 2022 Sep 14;10(9):E1163-E1168. doi: 10.1055/a-1873-0961. eCollection 2022 Sep.
7
Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.与炎症性肠病患者原发性硬化性胆管炎主要放射学进展相关的因素。
Hepatol Int. 2020 Dec;14(6):1114-1124. doi: 10.1007/s12072-020-10110-5. Epub 2020 Dec 28.
8
Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management.原发性硬化性胆管炎:诊断与管理简述。
Dig Dis Sci. 2019 Mar;64(3):632-642. doi: 10.1007/s10620-019-05484-y. Epub 2019 Feb 6.
9
Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.基质金属蛋白酶-2 和基质金属蛋白酶-9 基因多态性与肝硬化患者肝肺综合征风险的相关性:一项病例对照研究。
Kaohsiung J Med Sci. 2018 Nov;34(11):634-642. doi: 10.1016/j.kjms.2018.06.006. Epub 2018 Jul 25.
10
Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎不良结局的超声心动图和心电图预测指标
J Clin Exp Hepatol. 2017 Dec;7(4):321-327. doi: 10.1016/j.jceh.2017.05.007. Epub 2017 May 15.